Dr. Madhu Chaudhry
Overview
My primary focus is to deliver high-quality and compassionate care to patients. I aim to treat all my patients like I would want my own family members to be treated. My grandmother died of gall bladder cancer. I accompanied her to all her appointments and that experience led me to choose the field of hematology-oncology. Trust between patients and their oncologists is paramount, and I strive to be my patients' trusted friend. Open discussion of all available treatment options and active participation of the patient is extremely important to me. Making patients aware of all evidence-based treatments and ongoing clinical trials before we create a mutually agreed upon treatment plan is crucial. I am always available to discuss various issues that may arise as part of a patient's treatment plan.
Dr. Chaudhry is rated as an Experienced provider by MediFind in the treatment of Cyclic Neutropenia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Relapsed Refractory Multiple Myeloma (RRMM), and Multiple Myeloma.
Her clinical research consists of co-authoring 1 peer reviewed article and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
566 Ruin Creek Rd, Henderson, NC 27536
500 Lauchwood Dr, Laurinburg, NC 28352
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Stephen Tremont is an Oncologist and a Hematologist in Raleigh, North Carolina. Dr. Tremont is rated as an Advanced provider by MediFind in the treatment of Cyclic Neutropenia. His top areas of expertise are Hemoglobinopathy, Hemoglobin E Disease, Hemoglobin C Disease, and Essential Thrombocythemia. Dr. Tremont is currently accepting new patients.
University Of North Carolina At Chapel Hill
James Hathorn is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Hathorn is rated as a Distinguished provider by MediFind in the treatment of Cyclic Neutropenia. His top areas of expertise are Childhood Iron Deficiency Anemia, Multiple Myeloma, Iron Deficiency Anemia, and Non-Small Cell Lung Cancer (NSCLC). Dr. Hathorn is currently accepting new patients.
Duke Blood Cancer Center
I entered medical school for the sole purpose of learning more about human diseases, so that I could focus my laboratory efforts on improving the human condition. However, I was surprised to find myself drawn to clinical care. I care for people afflicted by acute leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. In this role, I have had the privilege of treating people facing life-threatening illnesses. I strive to gain the trust of each of my patients, so that I can help them make difficult treatment decisions. I engage in clinical research, evaluating novel agents that directly target the cancer cell to improve the degree of success in treating this illness. My patients benefit from my understanding of the newest available treatments, and also have access to promising investigational agents, when appropriate. In my faculty position at Duke University, I enjoy educating current oncologists as well as the next generation of physicians. Dr. Erba is rated as an Elite provider by MediFind in the treatment of Cyclic Neutropenia. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Chaudhry isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Chaudhry isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Adult Immune ThrombocytopeniaDr. Chaudhry isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AngiosarcomaDr. Chaudhry isAdvanced. Learn about Angiosarcoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Chaudhry isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Chaudhry isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Gastric LymphomaDr. Chaudhry isAdvanced. Learn about Gastric Lymphoma.
- Hemangioma Thrombocytopenia SyndromeDr. Chaudhry isAdvanced. Learn about Hemangioma Thrombocytopenia Syndrome.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Chaudhry isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Chaudhry isExperienced. Learn about Anal Cancer.
- AnemiaDr. Chaudhry isExperienced. Learn about Anemia.
- Aplastic AnemiaDr. Chaudhry isExperienced. Learn about Aplastic Anemia.
- Atypical Hemolytic Uremic Syndrome (aHUS)Dr. Chaudhry isExperienced. Learn about Atypical Hemolytic Uremic Syndrome (aHUS).
- B-Cell LymphomaDr. Chaudhry isExperienced. Learn about B-Cell Lymphoma.